Humanwell Healthcare Group Co

Humanwell Healthcare Group Co EBITDA per Employee

The EBITDA per Employee of Humanwell Healthcare Group Co (600079.SS) as of Oct 31, 2026 is 238,007.24 CNY. In the previous year, EBITDA per Employee was 192,307.00 CNY — a change of 23.76% (higher).

EBITDA per Employee

238,007.24CNY

YoY

23.76%

Last updated:

EBITDA per Employee of Humanwell Healthcare Group Co is 2025 238,007.24 CNY. EBITDA per Employee of Humanwell Healthcare Group Co was 2024 192,307.00 CNY. It decreases by 23.76% higher compared to the previous year.

The Humanwell Healthcare Group Co EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
131,564.41 CNY
Jan 1, 2019
134,297.72 CNY
Jan 1, 2020
151,578.83 CNY
Jan 1, 2021
159,835.96 CNY
Jan 1, 2022
243,008.30 CNY
Jan 1, 2023
238,619.07 CNY
Jan 1, 2024
192,307.00 CNY
Jan 1, 2025
238,007.24 CNY
The Humanwell Healthcare Group Co EBITDA per Employee history
YEAREBITDA per EmployeeYoY
238,007.24CNY+23.76%
192,307.00CNY-19.41%
238,619.07CNY-1.81%
243,008.30CNY+52.04%
159,835.96CNY+5.45%
151,578.83CNY+12.87%
134,297.72CNY+2.08%
131,564.41CNY-35.16%
202,903.11CNY+116.50%
93,720.72CNY+40.08%
66,904.87CNY+24.89%
53,569.44CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Humanwell Healthcare Group Co Stock analysis

What does Humanwell Healthcare Group Co do? Humanwell Healthcare (Group) Co., Ltd. generates revenue through the research and development, production, and sale of a diverse portfolio of medical products. The company’s offerings are categorized into chemical drugs, chemical raw material medicines, traditional Chinese medicines, biological medicines, and others, alongside the provision of medical instruments. This broad product range allows the firm to serve various healthcare needs across its operational scope. The company distributes its products in both domestic market and to overseas markets, indicating a dual-channel sales strategy that captures value from local and international customers. By engaging in the full lifecycle of medical product creation, from R&D to final sale, Humanwell Healthcare (Group) Co., Ltd. monetizes its extensive capabilities and wide distribution network to drive financial performance. Humanwell Healthcare Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Humanwell Healthcare Group Co stock

EBITDA per Employee of Humanwell Healthcare Group Co is 238,007.24 CNY in 2025.

EBITDA per Employee of Humanwell Healthcare Group Co changed from 192,307.00 CNY to 238,007.24 CNY, representing a 23.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Humanwell Healthcare Group Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Humanwell Healthcare Group Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Humanwell Healthcare Group Co

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Humanwell Healthcare Group Co